Criscuoli M - Search Results

1

Pharmacokinetics and pharmacodynamics of idrapril in rats, dogs, and humans.

Criscuoli M, Lippi A, Mengozzi G, Sardelli G, Subissi A, Giachetti A. Criscuoli M, et al. Drug Metab Dispos. 1993 Sep-Oct;21(5):835-40. Drug Metab Dispos. 1993. PMID: 7902245

2

Effects of idrapril calcium on tissue angiotensin-converting enzyme in rats.

Becagli P, Lippi A, Criscuoli M, Breschi MC, Subissi A. Becagli P, et al. Among authors: criscuoli m. J Cardiovasc Pharmacol. 1995 Jul;26(1):27-32. J Cardiovasc Pharmacol. 1995. PMID: 7564361

3

High-performance liquid chromatographic method with electrochemical detection for the determination of idrapril, a novel angiotensin-converting enzyme inhibitor, in biological matrices.

Lippi A, Criscuoli M, Sardelli G, Subissi A. Lippi A, et al. Among authors: criscuoli m. J Chromatogr B Biomed Appl. 1994 Oct 3;660(1):127-34. doi: 10.1016/0378-4347(94)00275-4. J Chromatogr B Biomed Appl. 1994. PMID: 7858705 Clinical Trial.

4

Oral pharmacokinetics and pharmacodynamics of idrapril calcium, the prototype of a new class of angiotensin converting enzyme inhibitors, in humans.

Criscuoli M, Subissi A, Coppini A, Capone P, Taddei S, Salvetti A. Criscuoli M, et al. J Hypertens Suppl. 1993 Dec;11(5):S340-1. J Hypertens Suppl. 1993. PMID: 8158413 Clinical Trial. No abstract available.

5

Inhibition of rabbit lung angiotensin converting enzyme by idrapril.

Lippi A, Criscuoli M, Sardelli G, Subissi A. Lippi A, et al. Among authors: criscuoli m. Biochem Pharmacol. 1993 Mar 24;45(6):1358-62. doi: 10.1016/0006-2952(93)90291-4. Biochem Pharmacol. 1993. PMID: 8385462

6

Reductive metabolism and its role in the disposition of the hydroxamic angiotensin-converting enzyme inhibitor idrapril calcium in rat.

Lippi A, Criscuoli M, Canali S, Subissi A. Lippi A, et al. Among authors: criscuoli m. Xenobiotica. 1996 May;26(5):551-8. doi: 10.3109/00498259609046731. Xenobiotica. 1996. PMID: 8736065

7

Alteration of cytochrome P-450 isozymes by captopril and idrapril in hepatic and renal microsomes of normotensive and spontaneously hypertensive rats.

Moretti A, Lippi A, Criscuoli M, Subissi A, Gervasi PG. Moretti A, et al. Among authors: criscuoli m. J Cardiovasc Pharmacol. 1997 Jul;30(1):12-8. doi: 10.1097/00005344-199707000-00003. J Cardiovasc Pharmacol. 1997. PMID: 9268216

8

Pharmacokinetics of the bicyclic peptide tachykinin NK2 receptor antagonist MEN 11420 (nepadutant) in rats.

Lippi A, Criscuoli M, Guelfi M, Santicioli P, Maggi CA. Lippi A, et al. Among authors: criscuoli m. Drug Metab Dispos. 1998 Nov;26(11):1077-81. Drug Metab Dispos. 1998. PMID: 9806949

9

Pharmacology of idrapril: a new class of angiotensin converting enzyme inhibitors.

Subissi A, Criscuoli M, Sardelli G, Guelfi M, Giachetti A. Subissi A, et al. Among authors: criscuoli m. J Cardiovasc Pharmacol. 1992 Jul;20(1):139-46. J Cardiovasc Pharmacol. 1992. PMID: 1383623

10

Catecholamines released from the adrenal medulla exert a compensatory, protective effect at beta 2-adrenoceptors against Paf-induced death in mice.

Criscuoli M, Subissi A. Criscuoli M, et al. Br J Pharmacol. 1988 Jan;93(1):132-8. doi: 10.1111/j.1476-5381.1988.tb11413.x. Br J Pharmacol. 1988. PMID: 2894872 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

104 results

Search Page

Filters